Works by Schellens, Jan H. M.

Results: 168

Evaluation of human neutrophil peptide-1, -2 and -3 as serum markers for colorectal cancer.

Published in:

Cancer Biomarkers, 2011, v. 7, n. 2, p. 109, doi. 10.3233/CBM-2010-0153

By:

van den Broek, Irene;
Sparidans, Rolf W.;
Engwegen, Judith Y. M. N.;
Cats, Annemieke;
Depla, Annekatrien C. T. M.;
Schellens, Jan H. M.;
Beijnen, Jos H.

Publication type:

Article

Phase I Study of Sorafenib Combined with Gemcitabine and Carboplatin in Patients with Advanced Solid Tumors.

Published in:

Oncology & Therapy, 2025, v. 13, n. 2, p. 465, doi. 10.1007/s40487-025-00340-8

By:

Voogd, Daphne W. M.;
Lucassen, Merel J. J.;
van der Noll, Ruud;
Zielhuis, Sybrand W. J.;
Boss, David;
Beijnen, Jos H.;
Rosing, Hilde;
Tibben, Matthijs;
Huitema, Alwin D. R.;
Schellens, Jan H. M.;
Steeghs, Neeltje

Publication type:

Article

The impact of liver resection on the dihydrouracil:uracil plasma ratio in patients with colorectal liver metastases.

Published in:

European Journal of Clinical Pharmacology, 2018, v. 74, n. 6, p. 737, doi. 10.1007/s00228-018-2426-4

By:

Jacobs, Bart A. W.;
Snoeren, Nikol;
Samim, Morsal;
Rosing, Hilde;
de Vries, Niels;
Deenen, Maarten J.;
Beijnen, Jos H.;
Schellens, Jan H. M.;
Koopman, Miriam;
van Hillegersberg, Richard

Publication type:

Article

The effect of seasonal variation and secretion of sunitinib in sweat on the development of hand–foot syndrome.

Published in:

European Journal of Clinical Pharmacology, 2013, v. 69, n. 12, p. 2065, doi. 10.1007/s00228-013-1579-4

By:

Lankheet, Nienke A. G.;
Huitema, Alwin D. R.;
Mallo, Henk;
Adriaansz, Sandra;
Haanen, John B. A. G.;
Schellens, Jan H. M.;
Beijnen, Jos H.;
Blank, Christian U.

Publication type:

Article

Screening for polymorphisms in the PXR gene in a Dutch population.

Published in:

European Journal of Clinical Pharmacology, 2006, v. 62, n. 5, p. 395, doi. 10.1007/s00228-006-0108-0

By:

Bosch, Tessa M.;
Deenen, Maarten;
Pruntel, Roelof;
Smits, Paul H. M.;
Schellens, Jan H. M.;
Beijnen, Jos H.;
Meijerman, Irma

Publication type:

Article

Severe Lactic Acidosis in a Diabetic Patient after Ethanol Abuse and Floor Cleaner Intake.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2014, v. 115, n. 5, p. 472, doi. 10.1111/bcpt.12251

By:

Hendrikx, Jeroen J. M. A.;
Lagas, Jurjen S.;
Daling, Ratana;
Hooijberg, Jan Hendrik;
Schellens, Jan H. M.;
Beijnen, Jos H.;
Brandjes, Desiderius P. M.;
Huitema, Alwin D. R.

Publication type:

Article

Tailored Tamoxifen Treatment for Breast Cancer Patients: A Perspective.

Published in:

Clinical Breast Cancer, 2015, v. 15, n. 4, p. 241, doi. 10.1016/j.clbc.2015.04.005

By:

Jager, Nynke G. L.;
Linn, Sabine C.;
Schellens, Jan H. M.;
Beijnen, Jos H.

Publication type:

Article

Development of a Framework for Cohort Simulation in Cost-Effectiveness Analyses Using a Multistep Ordinary Differential Equation Solver Algorithm in R.

Published in:

2013

By:

Frederix, Gerardus W. J.;
van Hasselt, Johan G. C.;
Severens, Johan L.;
Hövels, Anke M.;
Huitema, Alwin D. R.;
Raaijmakers, Jan A. M.;
Schellens, Jan H. M.

Publication type:

Journal Article

Acute poisoning after oral intake of a toluene-containing paint thinner.

Published in:

2002

By:

Malingré, Mirte M.;
Hendrix, Emile A.;
Schellens, Jan M.;
Koks, Cees W.;
Tibben, Matthijs M.;
Challa, Eric E.;
Beijnen, Jos H.;
Schellens, Jan H M;
Koks, Cees H W

Publication type:

journal article

Diagnostic and Therapeutic Strategies for Fluoropyrimidine Treatment of Patients Carrying Multiple DPYD Variants.

Published in:

Genes, 2018, v. 9, n. 12, p. 585, doi. 10.3390/genes9120585

By:

Lunenburg, Carin A. T. C.;
Henricks, Linda M.;
van Kuilenburg, André B. P.;
Mathijssen, Ron H. J.;
Schellens, Jan H. M.;
Gelderblom, Hans;
Guchelaar, Henk-Jan;
Swen, Jesse J.

Publication type:

Article

A Population Pharmacokinetic Model of Oral Docetaxel Coadministered With Ritonavir to Support Early Clinical Development.

Published in:

Journal of Clinical Pharmacology, 2020, v. 60, n. 3, p. 340, doi. 10.1002/jcph.1532

By:

Yu, Huixin;
Janssen, Julie M.;
Sawicki, Emilia;
van Hasselt, J. G. Coen;
de Weger, Vincent A.;
Nuijen, Bastiaan;
Schellens, Jan H. M.;
Beijnen, Jos H.;
Huitema, Alwin D. R.

Publication type:

Article

Selective Oral MEK1/2 Inhibitor Pimasertib: A Phase I Trial in Patients with Advanced Solid Tumors.

Published in:

2021

By:

Delord, Jean-Pierre;
Italiano, Antoine;
Awada, Ahmad;
Aftimos, Philippe;
Houédé, Nadine;
Lebbé, Céleste;
Pages, Celine;
Lesimple, Thierry;
Dinulescu, Monica;
Schellens, Jan H. M.;
Leijen, Suzanne;
Rottey, Sylvie;
Kruse, Vibeke;
Kefford, Richard;
Faivre, Sandrine;
Gomez-Roca, Carlos;
Scheuler, Armin;
Massimini, Giorgio;
Raymond, Eric

Publication type:

journal article

Selective Oral MEK1/2 Inhibitor Pimasertib in Metastatic Melanoma: Antitumor Activity in a Phase I, Dose-Escalation Trial.

Published in:

Targeted Oncology, 2021, v. 16, n. 1, p. 47, doi. 10.1007/s11523-020-00767-1

By:

Lebbé, Céleste;
Italiano, Antoine;
Houédé, Nadine;
Awada, Ahmad;
Aftimos, Philippe;
Lesimple, Thierry;
Dinulescu, Monica;
Schellens, Jan H. M.;
Leijen, Suzanne;
Rottey, Sylvie;
Kruse, Vibeke;
Kefford, Richard;
Raymond, Eric;
Faivre, Sandrine;
Pages, Celine;
Gomez-Roca, Carlos;
Schueler, Armin;
Goodstal, Samantha;
Massimini, Giorgio;
Delord, Jean-Pierre

Publication type:

Article

Simultaneous quantification of 2′,2′-difluorodeoxycytidine and 2′,2′-difluorodeoxyuridine nucleosides and nucleotides in white blood cells using porous graphitic carbon chromatography coupled with tandem mass spectrometry.

Published in:

Rapid Communications in Mass Spectrometry: RCM, 2009, v. 23, n. 19, p. 3040, doi. 10.1002/rcm.4212

By:

Jansen, Robert S.;
Rosing, Hilde;
Schellens, Jan H. M.;
Beijnen, Jos H.

Publication type:

Article

Liquid chromatography/tandem mass spectrometric method for the quantification of eight proteolytic fragments of ITIH<sub>4</sub> with biomarker potential in human plasma and serum.

Published in:

Rapid Communications in Mass Spectrometry: RCM, 2008, v. 22, n. 18, p. 2915, doi. 10.1002/rcm.3695

By:

van den Broek, Irene;
Sparidans, Rolf W.;
Schellens, Jan H. M.;
Beijnen, Jos H.

Publication type:

Article

Enhanced resolution triple-quadrupole mass spectrometry for ultra-sensitive and quantitative analysis of the investigational anticancer agent EO9 (apaziquone) and its metabolite EO5a in human and dog plasma to support (pre)-clinical studies of EOquin® given intravesically

Published in:

Rapid Communications in Mass Spectrometry: RCM, 2008, v. 22, n. 4, p. 462, doi. 10.1002/rcm.3387

By:

Vainchtein, Liia D.;
Rosing, Hilde;
Mirejovsky, Dorla;
Huynh, Van;
Lenaz, Luigi;
Schellens, Jan H. M.;
Beijnen, Jos H.

Publication type:

Article

Validated assay for the simultaneous determination of the anti-cancer agent gemcitabine and its metabolite 2′,2′-difluorodeoxyuridine in human plasma by high-performance liquid chromatography with tandem mass spectrometry.

Published in:

Rapid Communications in Mass Spectrometry: RCM, 2007, v. 21, n. 14, p. 2312, doi. 10.1002/rcm.3096

By:

Vainchtein, Liia D.;
Rosing, Hilde;
Thijssen, Bas;
Schellens, Jan H. M.;
Beijnen, Jos H.

Publication type:

Article

Determination of ruthenium originating from the investigational anti-cancer drug NAMI-A in human plasma ultrafiltrate, plasma, and urine by inductively coupled plasma mass spectrometry.

Published in:

Rapid Communications in Mass Spectrometry: RCM, 2007, v. 21, n. 9, p. 1521, doi. 10.1002/rcm.2985

By:

Brouwers, Elke E. M.;
Tibben, Matthijs M.;
Rosing, Hilde;
Schellens, Jan H. M.;
Beijnen, Jos H.

Publication type:

Article

Quantitative analysis of the farnesyl transferase inhibitor lonafarnib (Sarasar™, SCH66336) in human plasma using high-performance liquid chromatography coupled with tandem mass spectrometry.

Published in:

Rapid Communications in Mass Spectrometry: RCM, 2005, v. 19, n. 15, p. 2187, doi. 10.1002/rcm.2046

By:

Appels, Natalie M. G. M.;
van Maanen, Maria J.;
Rosing, Hilde;
Schellens, Jan H. M.;
Beijnen, Jos H.

Publication type:

Article

Quantitative determination of the novel anticancer drug E7070 (indisulam) and its metabolite (1,4-benzenedisulphonamide) in human plasma, urine and faeces by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry

Published in:

Rapid Communications in Mass Spectrometry: RCM, 2004, v. 18, n. 23, p. 2839, doi. 10.1002/rcm.1699

By:

Beumer, Jan Hendrik;
Rosing, Hilde;
Hillebrand, Michel J. X.;
Nan-Offeringa, Lianda G. A. H.;
Foley, Karen;
Yule, S. Murray;
Heck, Albert J. R.;
Schellens, Jan H. M.;
Beijnen, Jos H.

Publication type:

Article

Quantitative analysis of D-24851, a novel anticancer agent, in human plasma and urine by liquid chromatography coupled with tandem mass spectrometry.

Published in:

Rapid Communications in Mass Spectrometry: RCM, 2004, v. 18, n. 13, p. 1465, doi. 10.1002/rcm.1493

By:

Stokvis, Ellen;
Nan-Offeringa, Lianda G. A. H.;
Ouwehand, Mariët;
Tibben, Matthijs M.;
Rosing, Hilde;
Schnaars, Yvonne;
Grigat, Martina;
Romeis, Peter;
Schellens, Jan H. M.;
Beijnen, Jos H.

Publication type:

Article

Hot flashes are not predictive for serum concentrations of tamoxifen and its metabolites.

Published in:

BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-612

By:

Jager, Nynke G. L.;
Koornstra, Rutger H. T.;
Vincent, Andrew D.;
van Schaik, Ron H. N.;
Huitema, Alwin D. R.;
Korse, Tiny M.;
Schellens, Jan H. M.;
Linn, Sabine C.;
Beijnen, Jos H.

Publication type:

Article

Hot flashes are not predictive for serum concentrations of tamoxifen and its metabolites.

Published in:

2013

By:

Jager, Nynke Gl;
Koornstra, Rutger Ht;
Vincent, Andrew D;
van Schaik, Ron Hn;
Huitema, Alwin Dr;
Korse, Tiny M;
Schellens, Jan Hm;
Linn, Sabine C;
Beijnen, Jos H;
Jager, Nynke G L;
Koornstra, Rutger H T;
van Schaik, Ron H N;
Huitema, Alwin D R;
Schellens, Jan H M

Publication type:

journal article

Simultaneous population pharmacokinetic modelling of plasma and intracellular PBMC miltefosine concentrations in New World cutaneous leishmaniasis and exploration of exposure-response relationships.

Published in:

2018

By:

Kip, Anke E;
Castro, María del Mar;
Gomez, Maria Adelaida;
Cossio, Alexandra;
Schellens, Jan H M;
Beijnen, Jos H;
Saravia, Nancy Gore;
Dorlo, Thomas P C;
Castro, María Del Mar

Publication type:

journal article

Corrigendum to “Semiphysiological versus Empirical Modelling of the Population Pharmacokinetics of Free and Total Cefazolin during Pregnancy”.

Published in:

BioMed Research International, 2015, v. 2015, p. 1, doi. 10.1155/2015/124035

By:

van Hasselt, J. G. Coen;
Allegaert, Karel;
van Calsteren, Kristel;
Beijnen, Jos H.;
Schellens, Jan H. M.;
Huitema, Alwin D. R.

Publication type:

Article

Semiphysiological versus Empirical Modelling of the Population Pharmacokinetics of Free and Total Cefazolin during Pregnancy.

Published in:

BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/897216

By:

van Hasselt, J. G. Coen;
Allegaert, Karel;
van Calsteren, Kristel;
Beijnen, Jos H.;
Schellens, Jan H. M.;
Huitema, Alwin D. R.

Publication type:

Article

A Phase II Study of Patupilone (EPO906) in Patients With Platinum-Resistant or Platinum-Refractory Ovarian Cancer.

Published in:

Clinical Ovarian & Other Gynecologic Cancer, 2012, v. 5, n. 2, p. 53, doi. 10.1016/j.cogc.2012.06.001

By:

Smit, Willem M.;
Šufliarsky, Jozef;
Werner, Theresa L.;
Dizon, Don S.;
Wagnerová, Maria;
Hirte, Holger W.;
Spirtos, Nick M.;
Oza, Amit;
Dirix, Luc;
El-Hashimy, Mona;
Acharyya, Suddhasatta;
Tan, Eugene Y.;
Weber, Dirk;
Schellens, Jan H. M.

Publication type:

Article

Persistent neuropathy after treatment with cisplatin and oxaliplatin.

Published in:

Acta Oncologica, 2009, v. 48, n. 6, p. 832, doi. 10.1080/02841860902806609

By:

BROUWERS, ELKE E. M.;
HUITEMA, ALWIN D. R.;
BOOGERD, WILLEM;
BEIJNEN, JOS H.;
SCHELLENS, JAN H. M.

Publication type:

Article

Germline polymorphisms in patients with advanced nonsmall cell lung cancer receiving first-line platinum-gemcitabine chemotherapy.

Published in:

Cancer (0008543X), 2012, v. 118, n. 9, p. 2466, doi. 10.1002/cncr.26562

By:

Joerger, Markus;
Burgers, Sjaak A.;
Baas, Paul;
Smit, Egbert F.;
Haitjema, Tjeerd J.;
Bard, Martin P. L.;
Doodeman, Valerie D.;
Smits, Paul H. M.;
Vincent, Andrew;
Huitema, Alwin D. R.;
Beijnen, Jos H.;
Schellens, Jan H. M.

Publication type:

Article

Design of a Drug-Drug Interaction Study of Vincristine With Azole Antifungals in Pediatric Cancer Patients Using Clinical Trial Simulation.

Published in:

Pediatric Blood & Cancer, 2014, v. 61, p. 2223, doi. 10.1002/pbc.25198

By:

van Hasselt, J. G. Coen;
van Eijkelenburg, Natasha K. A.;
Beijnen, Jos H.;
Schellens, Jan H. M.;
Huitema, Alwin D. R.

Publication type:

Article

Population Pharmacokinetics and Pharmacodynamics for Treatment Optimization in Clinical Oncology.

Published in:

Clinical Pharmacokinetics, 2008, v. 47, n. 8, p. 487, doi. 10.2165/00003088-200847080-00001

By:

Zandvliet, Anthe S.;
Schellens, Jan H. M.;
Beijnen, Jos H.;
Huitema, Alwin D. R.

Publication type:

Article

Mass balance studies, with a focus on anticancer drugs.

Published in:

2006

By:

Beumer, Jan H.;
Beijnen, Jos H.;
Schellens, Jan H. M.

Publication type:

journal article

PRESCRIPTION ERROR RESULTING IN VALPROIC ACID INTOXICATION.

Published in:

2004

By:

Frankfort, Suzanne V.;
Tulner, Linda R.;
Knol, Wilma;
van Campen, Jos P. C. M.;
Schellens, Jan H. M.;
Beijnen, Jos H.

Publication type:

Letter

Pharmacodynamic modeling of cardiac biomarkers in breast cancer patients treated with anthracycline and trastuzumab regimens.

Published in:

Journal of Pharmacokinetics & Pharmacodynamics, 2018, v. 45, n. 3, p. 431, doi. 10.1007/s10928-018-9579-8

By:

de Vries Schultink, Aurelia H. M.;
Boekhout, Annelies H.;
Gietema, Jourik A.;
Burylo, Artur M.;
Dorlo, Thomas P. C.;
van Hasselt, J. G. Coen;
Schellens, Jan H. M.;
Huitema, Alwin D. R.

Publication type:

Article

Phase I study of lapatinib plus trametinib in patients with KRAS-mutant colorectal, non-small cell lung, and pancreatic cancer.

Published in:

2020

By:

Huijberts, Sanne C. F. A.;
van Geel, Robin M. J. M.;
van Brummelen, Emilie M. J.;
Opdam, Frans L.;
Marchetti, Serena;
Steeghs, Neeltje;
Pulleman, Saskia;
Thijssen, Bas;
Rosing, Hilde;
Monkhorst, Kim;
Huitema, Alwin D. R.;
Beijnen, Jos H.;
Bernards, René;
Schellens, Jan H. M.

Publication type:

journal article

A Phase 1, open-label, multicentre study to compare the capsule and tablet formulations of AZD5363 and explore the effect of food on the pharmacokinetic exposure, safety and tolerability of AZD5363 in patients with advanced solid malignancies: OAK.

Published in:

2018

By:

Dean, Emma;
Banerji, Udai;
Schellens, Jan H. M.;
Krebs, Matthew G.;
Jimenez, Begona;
van Brummelen, Emilie;
Bailey, Chris;
Casson, Ed;
Cripps, Diana;
Cullberg, Marie;
Evans, Stephen;
Foxley, Andrew;
Lindemann, Justin;
Rugman, Paul;
Taylor, Nigel;
Turner, Guy;
Yates, James;
Lawrence, Peter

Publication type:

journal article

A drug-drug interaction study to assess the effect of the CYP1A2 inhibitor fluvoxamine on the pharmacokinetics of dovitinib (TKI258) in patients with advanced solid tumors.

Published in:

2018

By:

de Weger, Vincent A.;
Goel, Sanjay;
von Moos, Roger;
Schellens, Jan H. M.;
Mach, Nicholas;
Tan, Eugene;
Anand, Suraj;
Scott, Jeffrey W.;
Lassen, Ulrik

Publication type:

journal article

Patients homozygous for DPYD c.1129-5923C>G/haplotype B3 have partial DPD deficiency and require a dose reduction when treated with fluoropyrimidines.

Published in:

2016

By:

Meulendijks, Didier;
Henricks, Linda;
Kuilenburg, André;
Jacobs, Bart;
Aliev, Abidin;
Rozeman, Lisette;
Meijer, Judith;
Beijnen, Jos;
Graaf, Hiltje;
Cats, Annemieke;
Schellens, Jan;
Henricks, Linda M;
van Kuilenburg, André B P;
Jacobs, Bart A W;
Beijnen, Jos H;
de Graaf, Hiltje;
Schellens, Jan H M

Publication type:

journal article

A phase 0 clinical trial of novel candidate extended-release formulations of capecitabine.

Published in:

2016

By:

Jacobs, Bart;
Meulenaar, Jelte;
Rosing, Hilde;
Pluim, Dick;
Tibben, Matthijs;
Vries, Niels;
Nuijen, Bastiaan;
Huitema, Alwin;
Beijnen, Jos;
Schellens, Jan;
Marchetti, Serena;
Jacobs, Bart A W;
Tibben, Matthijs M;
de Vries, Niels;
Huitema, Alwin D R;
Beijnen, Jos H;
Schellens, Jan H M

Publication type:

journal article

Phase 1a/1b and pharmacogenetic study of docetaxel, oxaliplatin and capecitabine in patients with advanced cancer of the stomach or the gastroesophageal junction.

Published in:

2015

By:

Deenen, Maarten;
Meulendijks, Didier;
Boot, Henk;
Legdeur, Marie-Cecile;
Beijnen, Jos;
Schellens, Jan;
Cats, Annemieke;
Deenen, Maarten J;
Legdeur, Marie-Cecile J C;
Beijnen, Jos H;
Schellens, Jan H M

Publication type:

journal article

Carboplatin dosing in overweight and obese patients with normal renal function, does weight matter?

Published in:

Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 115, doi. 10.1007/s00280-008-0856-x

By:

Ekhart, Corine;
Rodenhuis, Sjoerd;
Schellens, Jan H. M.;
Beijnen, Jos H.;
Huitema, Alwin D. R.

Publication type:

Article

Metabolism of trabectedin (ET-743, Yondelis™) in patients with advanced cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 6, p. 825, doi. 10.1007/s00280-006-0342-2

By:

Beumer, Jan H.;
Rademaker-Lakhai, Jeany M.;
Rosing, Hilde;
Hillebrand, Michel J. X.;
Bosch, Tessa M.;
Lopez-Lazaro, Luis;
Schellens, Jan H. M.;
Beijnen, Jos H.

Publication type:

Article

The effect of hydroxyurea on P-glycoprotein/BCRP-mediated transport and CYP3A metabolism of imatinib mesylate.

Published in:

Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 6, p. 855, doi. 10.1007/s00280-006-0334-2

By:

Oostendorp, Roos L.;
Marchetti, Serena;
Beijnen, Jos H.;
Mazzanti, R.;
Schellens, Jan H. M.

Publication type:

Article

Absence of N-linked glycosylation does not affect plasma membrane localization of breast cancer resistance protein (BCRP/ABCG2).

Published in:

2005

By:

Mohrmann, Karin;
Eijndhoven, Maria A. J.;
Schinkel, Alfred H.;
Schellens, Jan H. M.;
van Eijndhoven, Maria A J

Publication type:

journal article

Phase I study of an oral formulation of irinotecan administered daily for 14 days every 3 weeks in patients with advanced solid tumours.

Published in:

2005

By:

Schoemaker, Nadja E.;
Kuppens, I. E. L. M.;
Ten Bokkel Huinink, Wim W.;
Lefebvre, Patricia;
Beijnen, Jos H.;
Assadourian, Sylvie;
Sanderink, Ger-Jan;
Schellens, Jan H. M.;
Huinink, Wim W Ten Bokkel

Publication type:

journal article

Cytotoxicity of the organic ruthenium anticancer drug Nami-A is correlated with DNA binding in four different human tumor cell lines.

Published in:

Cancer Chemotherapy & Pharmacology, 2004, v. 54, n. 1, p. 71, doi. 10.1007/s00280-004-0773-6

By:

Pluim, Dick;
van Waardenburg, Robert C. A. M.;
Beijnen, Jos H.;
Schellens, Jan H. M.

Publication type:

Article

Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 4, p. 329, doi. 10.1007/s00280-003-0719-4

By:

Zamboni, William C.;
Gervais, Anne C.;
Egorin, Merrill J.;
Schellens, Jan H. M.;
Zuhowski, Elleanor G.;
Pluim, Dick;
Joseph, Erin;
Hamburger, Deborah R.;
Working, Peter K.;
Colbern, Gail;
Tonda, Margaret E.;
Potter, Douglas M.;
Eiseman, Julie L.

Publication type:

Article

Urinary and fecal excretion of topotecan in patients with malignant solid tumours.

Published in:

Cancer Chemotherapy & Pharmacology, 2002, v. 50, n. 1, p. 59, doi. 10.1007/s00280-002-0454-2

By:

Herben, Virginie M. M.;
Schoemaker, Nadja E.;
Rosing, Hilde;
van Zomeren, Desiree M.;
ten Bokkel Huinink, Wim W.;
Dubbelman, Ria;
Hearn, Solange;
Schellens, Jan H. M.;
Beijnen, Jos H.

Publication type:

Article

Population pharmacokinetics of the novel anticancer agent KRN7000.

Published in:

Cancer Chemotherapy & Pharmacology, 2002, v. 49, n. 4, p. 287, doi. 10.1007/s00280-001-0413-3

By:

Crul, Mirjam;
Mathôt, Ron A. A.;
Giaccone, Giuseppe;
Punt, Cornelis J. A.;
Rosing, Hilde;
Hillebrand, Michel J. X.;
Ando, Yoshitaka;
Nishi, Nobosuke;
Tanaka, Hideji;
Schellens, Jan H. M.;
Beijnen, Jos H.

Publication type:

Article

Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin.

Published in:

Cancer Chemotherapy & Pharmacology, 2002, v. 49, n. 3, p. 201, doi. 10.1007/s002800100371

By:

Terwogt, Jetske M. Meerum;
Groenewegen, Gerard;
Pluim, Dick;
Maliepaard, Marc;
Tibben, Matthijs M.;
Huisman, Albert;
ten Bokkel Huinink, Wim W.;
Schot, Margaret;
Welbank, Helen;
Voest, Emile E.;
Beijnen, Jos H.;
Schellens, Jan H. M.

Publication type:

Article